Compile Data Set for Download or QSAR

Found 2 hits Enz. Inhib. hit(s) with Target = 'Proto-oncogene tyrosine-protein kinase Src' and Ligand = 'BDBM247064'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM247064 (3-((4-((4-(3-(3-Isopropyl-1-(p-tolyl)-1H-pyrazol-5...) Show SMILES COc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)C)c4ccccc34)n2)cc(c1)C(=O)NCCN1CCOCC1 Show InChI InChI=1S/C42H45N9O5/c1-27(2)36-26-38(51(49-36)31-11-9-28(3)10-12-31)47-42(53)46-35-13-14-37(34-8-6-5-7-33(34)35)56-39-15-16-44-41(48-39)45-30-23-29(24-32(25-30)54-4)40(52)43-17-18-50-19-21-55-22-20-50/h5-16,23-27H,17-22H2,1-4H3,(H,43,52)(H,44,45,48)(H2,46,47,53)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9701670 (2017) BindingDB Entry DOI: 10.7270/Q2JM2CP2
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM247064 (3-((4-((4-(3-(3-Isopropyl-1-(p-tolyl)-1H-pyrazol-5...) Show SMILES COc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)C)c4ccccc34)n2)cc(c1)C(=O)NCCN1CCOCC1 Show InChI InChI=1S/C42H45N9O5/c1-27(2)36-26-38(51(49-36)31-11-9-28(3)10-12-31)47-42(53)46-35-13-14-37(34-8-6-5-7-33(34)35)56-39-15-16-44-41(48-39)45-30-23-29(24-32(25-30)54-4)40(52)43-17-18-50-19-21-55-22-20-50/h5-16,23-27H,17-22H2,1-4H3,(H,43,52)(H,44,45,48)(H2,46,47,53)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	41	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9701670 (2017) BindingDB Entry DOI: 10.7270/Q2JM2CP2
					More data for this Ligand-Target Pair